Inovio Pharmaceuticals
Inovio Pharmaceuticals is an American clinical‑stage biotech company specializing in synthetic DNA medicines and vaccines for cancer and infectious diseases.
It develops proprietary DNA‑based therapies including plasmid vaccines and the Cellectra delivery device to stimulate immune responses against HPV, cancer, and viruses.
Address: 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462
Phone: (267) 440-4200
-
With FDA Decision Looming, Plymouth Meeting’s Inovio Cuts Workforce to Preserve Cash
Over the past year, Plymouth Meeting-based Inovio Pharmaceuticals has reduced its workforce by 16 percent to preserve cash as it…
-
Plymouth Meeting-based Inovio Expects to Raise $36M Following “Transformational” 2023
Plymouth Meeting-based Inovio Pharmaceuticals is expecting to raise $36 million through a stock offering this week, writes John George for…
-
Inovio Getting Closer to Seeking FDA Approval for Its First DNA Medicine
Plymouth Meeting’s Inovio Pharmaceuticals is getting closer to seeking U.S. Food & Drug Administration approval for its first DNA medicine,…
-
Plymouth Meeting’s Inovio on Track to Launch First DNA Medicine in U.S.
Plymouth Meeting-based Inovio Pharmaceuticals is on the right track to launch its first product which would also be the first…
-
Plymouth Meeting Pharmaceutical Company Undergoes Third Round of Layoffs
Inovio Pharmaceuticals in Plymouth Meeting continues to trim its workforce. In this third round of layoffs in 13 months, the…
-
Plymouth Meeting-based Inovio Replaces CEO, Switches Focus from COVID-19 Vaccine to Developing Booster
Plymouth Meeting-based Inovio has replaced co-founder J. Joseph Kim as CEO and announced that it will shift its focus from…
-
Plymouth Meeting-based Geneos Therapeutics, Inovio Spin Off, Raises $17M in Private Stock Sale
Inovio Pharmaceuticals spinoff Geneos Therapeutics, a Plymouth Meeting clinical stage biotherapeutics company, has raised $17 million in a private stock…
-
Plymouth Meeting-based Inovio Hopes New Strategy Will Lead to Regulatory Approval for Its COVID-19 Vaccine
Plymouth Meeting-based Inovio is adopting a new strategy in the hopes of gaining regulatory approval for its COVID-19 vaccine candidate,…
-
Plymouth Meeting-based Inovio Expands Late-Stage Testing of COVID-19 Vaccine Candidate to Colombia
Plymouth Meeting-based Inovio Pharmaceuticals has expanded the late-stage testing of its COVID-19 vaccine candidate it is working on with China’s…
-
Plymouth Meeting-based Inovio Plans to Take COVID-19 Vaccine Trials Overseas
Plymouth Meeting-based Inovio Pharmaceuticals saw its stock drop by 25 percent last week. This was after the U.S. government decided…
-
Plymouth Meeting-based Inovio Signs Licensing Agreement with China’s Advaccine for Its COVID-19 DNA Vaccine Candidate
Plymouth Meeting-based Inovio saw its stock jump after signing a collaboration and license agreement with Advaccine Biopharmaceuticals Suzhou for its…
-
Plymouth Meeting-based Inovio’s Immunotherapy Startup Raises $10.4M in Private Stocks
Geneos Therapeutics, the cancer immunotherapy startup that is a spinoff of Plymouth Meeting-based Inovio, has managed to raise $10.4 million…
-
Plymouth Meeting-based Inovio Waiting for FDA Approval to Start COVID-19 Vaccine Trials
Plymouth Meeting-based Inovio Pharmaceuticals is waiting for approval from the FDA to start the next stage of trials for its…
-
FDA Places Clinical Hold on Plymouth Meeting’s Inovio’s COVID-19 Vaccine
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze…
-
Health & Fitness, Healthcare, Limerick, Pharma & Biotech, Plymouth Meeting, Radnor, Temporary, WayneBig and Small Local Biotech, Pharmaceutical Companies Working on COVID-19 Vaccine
A growing number of local pharmaceutical, biotech, and medical device companies are joining efforts to develop a COVID-19 vaccine, writes…
-
Plymouth Meeting’s Inovio Sees Highest Stock Value Jump in Philadelphia Region During Pandemic
While many companies in the Philadelphia region have seen their share price decimated during the coronavirus pandemic, conversely Plymouth Meeting-based…
-
Bloomberg Businessweek: Plymouth Meeting’s Inovio’s COVID-19 Vaccine Among Most Promising
Drug companies and university scientists across the world are working around the clock to find a vaccine against COVID-19 and…
-
Several Montgomery County Companies Are at Heart of Search for Coronavirus Vaccine
As the search for the coronavirus vaccine continues, several local companies are at the heart of this crucially important process,…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
